CFM
ACHV icon

Catalyst Funds Management’s Achieve Life Sciences ACHV Stock Holding History

Catalyst Funds Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,000
Closed -$52.9K – 645
2026
Q1 		$52.9K Buy
+18,000
New +$79.9K 0.01% 537

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Catalyst Funds Management's ACHV Position: Q2 2026 in Review

Catalyst Funds Management sold out of Achieve Life Sciences (ACHV) in Q2 2026, closing a stake of 18,000 shares — an estimated $52.9K sold.

Catalyst Funds Management first reported a position in ACHV in Q1 2026 and held it in 1 quarter. The position peaked at $52.9K in Q1 2026. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Catalyst Funds Management reported no remaining Achieve Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Catalyst Funds Management sold 18,000 Achieve Life Sciences shares in Q2 2026, an estimated $52.9K.
  • Catalyst Funds Management first reported a position in Achieve Life Sciences in Q1 2026 and held it in 1 quarter.
  • Catalyst Funds Management's Achieve Life Sciences position peaked at $52.9K in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.